Skip to main content

Table 2 OHSI patient’s description

From: Early referral and control of disease’s flares prevent Orthopedic and Hand Surgery Indication (OHSI) in a dynamic cohort of Hispanic early rheumatoid arthritis patients

Number of patient DR months Baseline DAS28 OHSI DAS28 Follow-up to OHSI, months Treatment at OHSI Surgical indication
1a 7.3 5.6 3.4 110 MTX + SUL + LEF + PDN Left hip arthroplasty
2a 4.7 7.2 2.4 114 MTX + PDN Right knee arthroplasty
3a 7.6 8.7 6.4 68 MTX + PDN Left hip arthroplasty
4a 1 7.1 3.0 132 MTX + PDN Hemi-resection of the distal ulna and extensor tendon’s reconstruction (right hand)
5 8.8 7.8 2.4 146 MTX + PDN Extensor tendon’s reconstruction (left hand)
6 6 5.8 3.4 124 CLQ + SUL + PDN Right hip arthroplasty
7 10.5 5.3 2.5 72 MTX + CLQ + PDN Right knee arthroplasty
8a 6.7 4.6 5.2 114 AZA + PDN Extensor tendon’s reconstruction (left hand)
9a 9.5 8.0 2.3 66 MTX + PDN Left shoulder arthroplasty
10a 7.2 7.1 2.6 52 MTX + CLQ + SUL + PDN Right hand synovectomy
11 12.1 5.3 2.2 14 MTX + CLQ + SUL Right knee arthroplasty
12a 8.5 6.8 2.5 14 MTX + CLQ + SUL + PDN Left hip arthroplasty
  1. DAS28 Disease activity score (28 joints evaluated), MTX methotrexate, SUL sulphasalazine, LEF leflunomide, PDN prednisone, CLQ chloroquine, AZA azathioprine, F female, M male, DR months of symptom’s disease duration up to cohort baseline evaluation, DAS28 disease activity
  2. aPatients already intervened